REGN CIK: 872589

Regeneron Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
7.08
FY22:
5.01
FY23:
4.59
FY24:
4.42
FY25:
4.98
Change from FY21 to FY25
billions USD
FY21:
−5.38
FY22:
−3.78
FY23:
−3.19
FY24:
−2.47
FY25:
−0.63
Change from FY21 to FY25
billions USD
FY21:
−1.01
FY22:
−1.01
FY23:
−1.79
FY24:
−2.20
FY25:
−3.72
billions USD
FY21:
0.69
FY22:
0.22
FY23:
−0.38
FY24:
−0.25
FY25:
0.63
(positive)
Change from FY21 to FY25
billions USD
FY21:
6.53
FY22:
4.42
FY23:
3.88
FY24:
3.66
FY25:
4.08

All amounts in billions USD Data source:SEC EDGAR